Cancer Therapeutics Market is estimated to account for over US$ 140 billion by 2019. The market is anticipated to grow at a CAGR of ~7.7% from 2019 to 2030.
The market growth can be attributed to several factors, which has led to its wide-scale adoption. The increasing cancer prevalence globally and rising collaboration between pharmaceutical companies for cancer research activities are anticipated to further contribute to the substantial growth of the market between 2019 and 2030. However, high cost of this therapy for treatment along with adverse effects associated with cancer therapeutics is likely to restrain market growth to a certain extent.
Major Key Players of the Cancer Therapeutics Market are:
Amgen Inc., Bayer AG, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company among others.
No comments:
Post a Comment